180 related articles for article (PubMed ID: 2243335)
21. The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
Grover GJ; D'Alonzo AJ; Sleph PG; Dzwonczyk S; Hess TA; Darbenzio RB
J Pharmacol Exp Ther; 1994 May; 269(2):536-40. PubMed ID: 8182522
[TBL] [Abstract][Full Text] [Related]
22. Potassium channel opener-augmented cardioplegia: protection of myocyte contractility with chronic left ventricular dysfunction.
Dorman BH; Hebbar L; Clair MJ; Hinton RB; Roy RC; Spinale FG
Circulation; 1997 Nov; 96(9 Suppl):II-253-9. PubMed ID: 9386107
[TBL] [Abstract][Full Text] [Related]
23. Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.
Urquhart RA; Ford WR; Broadley KJ
J Cardiovasc Pharmacol; 1993 Feb; 21(2):279-88. PubMed ID: 7679163
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
25. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
[TBL] [Abstract][Full Text] [Related]
26. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
27. The antitussive effect of cromakalim in rats is not associated with adenosine triphosphate sensitive K+ channels.
Kamei J; Iwamoto Y; Narita M; Suzuki T; Misawa M; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):201-10. PubMed ID: 8391711
[TBL] [Abstract][Full Text] [Related]
28. External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle.
Bott A; Eltze M; Illes P
Eur J Pharmacol; 1992 Mar; 213(1):141-4. PubMed ID: 1499650
[TBL] [Abstract][Full Text] [Related]
29. Na+1-activated and ATP-sensitive K+ channels in the heart.
Sanguinetti MC
Prog Clin Biol Res; 1990; 334():85-109. PubMed ID: 2137936
[No Abstract] [Full Text] [Related]
30. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
Grover GJ; Newburger J; Sleph PG; Dzwonczyk S; Taylor SC; Ahmed SZ; Atwal KS
J Pharmacol Exp Ther; 1991 Apr; 257(1):156-62. PubMed ID: 2019983
[TBL] [Abstract][Full Text] [Related]
31. Effects of levcromakalim and glibenclamide on paced guinea-pig atrial strips exposed to hypoxia.
Mellemkjaer S; Nielsen-Kudsk JE
Eur J Pharmacol; 1995 Apr; 277(1):51-6. PubMed ID: 7635172
[TBL] [Abstract][Full Text] [Related]
32. Actions of potassium channel openers in rat detrusor urinae.
Ha JH; Lee KY; Kim WJ
J Korean Med Sci; 1993 Feb; 8(1):53-9. PubMed ID: 8343221
[TBL] [Abstract][Full Text] [Related]
33. Effects of potassium channel openers on single potassium channels in mouse skeletal muscle.
Weik R; Neumcke B
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):258-63. PubMed ID: 2280794
[TBL] [Abstract][Full Text] [Related]
34. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
Sellers AJ; Boden PR; Ashford ML
Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
[TBL] [Abstract][Full Text] [Related]
35. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
36. Effects of three K+ channel openers on airways and pulmonary circulation in the isolated guinea-pig lung.
Dumas M; Dumas JP; Advenier C; Giudicelli JF
Eur J Pharmacol; 1993 Aug; 239(1-3):141-7. PubMed ID: 8223889
[TBL] [Abstract][Full Text] [Related]
37. The effects of pharmacological modulation of KATP on the guinea-pig isolated diaphragm.
Wickenden AD; Prior H; Kelly E; Russell K; Poucher SM; Kumar P
Eur J Pharmacol; 1996 Apr; 302(1-3):79-88. PubMed ID: 8790995
[TBL] [Abstract][Full Text] [Related]
38. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
Lau WM
Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969
[TBL] [Abstract][Full Text] [Related]
39. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solution.
Grover GJ; Sleph PG
J Cardiovasc Pharmacol; 1995 Nov; 26(5):698-706. PubMed ID: 8637183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
